Rajan Kulkarni, Ph.D., M.D.

  • Associate Professor of Dermatology, School of Medicine
  • Member, CEDAR, OHSU Knight Cancer Institute, School of Medicine
  • M.D./Ph.D. Program Committee, School of Medicine


Dr. Kulkarni’s research focuses on the intersection of basic biology, technology, and medicine to help better realize the vision of personalized medicine in cancer.  His research is focused on basic and translational studies to enable molecularly-based, personalized approaches to cancer care, in collaboration with the VA, the Center for Early Detection Research (CEDAR), and the Knight Cancer Institute (KCI).  A parallel line of research focuses on oncodermatology and elucidating the mechanisms by which novel chemotherapeutics and immunotherapies cause skin toxicities/rashes and whether these mechanisms have any correlation with anti-tumor effect and overall outcome. The overall goal is to couple genomic, epigenetic, and clinical information to design novel treatment strategies and ultimately improve patient outcomes.

In his spare time, Dr. Kulkarni enjoys spending time with his family and son. He enjoys exploring the great outdoors, both in the Portland area and throughout the Pacific Northwest.

Education and training

    • Ph.D., 2006, California Institute of Technology
    • M.D., 2009, David Geffen School of Medicine at UCLA
  • Residency

    • Dermatology, University of California Los Angeles, 2014
  • Fellowship

    • Dermatology-STAR Research Fellowship, University of California Los Angeles, 2014
  • Certifications

    • American Board of Dermatology, 2014

Memberships and associations:

  • American Academy of Dermatology
  • Society of Investigative Dermatology
  • American Association of Cancer Research
  • American Society of Clinical Oncology

Areas of interest

  • Skin cancers
  • Melanoma
  • Early detection
  • Cancers


Elsevier pure profile


  • {{ pub.journalAssociation.journal.name.text[0].value }}